Dr. Scott Gottlieb

Special Partner, New Enterprise Association

New York, NY


Dr. Gottlieb is also a resident fellow of the American Enterprise Institute. He served as 23rd Commissioner of the U.S. Food & Drug Administration from 2017 to 2019. Previously, he held several roles in the public and private sectors, including serving as FDA's Deputy Commission for Medical & Scientific Affairs and as a senior adviser to the Administrator of the Centers for Medicare and Medicaid Seervices.

  • 2020 Second Quarter

Added to: Illumina Inc. - San Diego, CA

Illumina develops tools for the research of genetics. Revenues are $4 billion.

  • 2019 Third Quarter

Added to: Pfizer Inc. - New York, NY

Pfizer develops healthcare products including medicines and vaccines. Revenues are $52 billion.